Huntingdon Life Sciences unveils new name post-Harlan integration

By Staff reporter

- Last updated on GMT

UK CRO was previously named after Huntingdon in Cambridgeshire
UK CRO was previously named after Huntingdon in Cambridgeshire
Preclinical CRO Huntingdon Life Sciences has announced a new name, which it changed to mark the integration of Harlan Laboratories.

The UK-based preclinical contractor announced its intention to come up with a fresh moniker in February, explaining that the decision to adopt a different sobriquet followed a “huge amount​” of internal integration work.

In a press statement last night, CEO Brian Cass said choosing the alternative appellation marked a “hugely exciting time for our company​” adding we “will be united with our customers in the knowledge that the research they conduct, and the products we help them develop, have the potential to enhance life​.”

Our new name and brand will reflect our integrated management structure and the broader product and service offerings of our combined organization​.”

Huntingdon - which bought Harlan last May​ – claims to be the third largest provider of preclinical services to the pharmaceutical industry.

The UK-headquartered firm employs 3,800 people and has annual sales of approximately $500m (€447m).

Related topics: Preclinical Research, Preclinical

Related news

Show more

Related product

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q² Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Related suppliers

Follow us

Products

View more

Webinars